PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents

NCT02325349 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Change in protocol strategy

Conditions

Advanced Head and Neck Carcinoma
Advanced Non-small Cell Lung Carcinoma

Interventions

DRUG: radiopharmaceutical (Flotegatide (18F) or RGD (68Ga)

Sponsor

Assistance Publique - Hôpitaux de Paris